Home › Dementia › California › Long Beach
Dementia clinical trials in Long Beach, CA
5 studies for Dementia are looking for participants at sites in and around Long Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
- Clinical Site, Long Beach
A Study of LY3439539 in Participants With Alzheimer's Disease
RecruitingPhase 1
- Healthy Brain Clinic, Long Beach
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- Long Beach VA Medical Center, Long Beach
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RecruitingPhase 3
- Healthy Brain Clinic, Long Beach
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
RecruitingPhase 3
- Healthy Brain Clinic, Long Beach
About Dementia
People with dementia have serious problems with two or more brain functions, such as memory and language. Affects the ability to do normal activities.
More about Dementia on MedlinePlus
Dementia trials in other cities
- Los Angeles, CA12 studies
- New York City, NY12 studies
- Chicago, IL10 studies
- Baltimore, MD8 studies
- San Diego, CA8 studies
- Boston, MA8 studies
- St. Louis, MO8 studies
- Durham, NC8 studies
- Orlando, FL8 studies
- Tampa, FL8 studies
- Atlanta, GA8 studies
- Indianapolis, IN8 studies
Other studies in Long Beach
- Non-Small Cell Lung Cancer12 studies
- Type 2 Diabetes11 studies
- Lung Cancer9 studies
- Breast Cancer9 studies
- Alzheimer's Disease8 studies
- Prostate Cancer7 studies
- Cancer (all types)6 studies
- Cardiovascular Disease6 studies
- Obesity5 studies
- Overweight5 studies
- Steatotic Liver Disease4 studies
- Burkitt Lymphoma4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.